LYL1 and Parkinson disease: Other transcription factors altered in male PD patients (i.e., BATF, CEBPA, ETS1, KLF6, LYL1, NFKB1, RELA, SOX13, SP3, SPI1, STAT1, STAT2, and STAT3) may participate in neuroinflammatory processes and regulate various functions of the immune response.